{"id":1066,"date":"2025-04-17T17:54:21","date_gmt":"2025-04-17T16:54:21","guid":{"rendered":"https:\/\/neuropsiquiatria.pt\/?page_id=1066"},"modified":"2025-10-20T05:54:16","modified_gmt":"2025-10-20T04:54:16","slug":"neuroterapia-comparativo","status":"publish","type":"page","link":"https:\/\/neuropsiquiatria.pt\/es\/neuroterapia-comparativo\/","title":{"rendered":"Neuroterapia VS Terapias Convencionales - Comparaci\u00f3n"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"1066\" class=\"elementor elementor-1066\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3c4307d e-flex e-con-boxed e-con e-parent\" data-id=\"3c4307d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-dd83e2f elementor-hidden-mobile elementor-widget elementor-widget-spacer\" data-id=\"dd83e2f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7220f20 elementor-hidden-desktop elementor-hidden-tablet elementor-widget elementor-widget-spacer\" data-id=\"7220f20\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9e7b4a2 elementor-widget elementor-widget-html\" data-id=\"9e7b4a2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!DOCTYPE html>\n<html lang=\"pt-PT\">\n<head>\n    <meta charset=\"UTF-8\">\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\n    <title>Neuroterapia VS Terapias Convenconais - Comparativo<\/title>\n    <style>\n        * {\n            box-sizing: border-box;\n            margin: 0;\n            padding: 0;\n            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;\n        }\n\n        body {\n            background-color: #e3fefd;\n            background-size: cover;\n            background-repeat: no-repeat;\n            background-position: center;\n            background-attachment: fixed;\n            color: #333;\n            line-height: 1.6;\n        }\n\n        .container {\n            max-width: 1200px;\n            margin: 0 auto;\n            padding: 20px;\n        }\n        \n        \/* ---------------------------------------------------- *\/\n        \/* NOVOS ESTILOS PARA REPLICAR O CABE\u00c7ALHO DA IMAGEM *\/\n        \/* ---------------------------------------------------- *\/\n\n        \/* Classe que ir\u00e1 substituir a antiga .section-title *\/\n        .page-header-container {\n            text-align: center;\n            margin-bottom: 40px;\n            padding-top: 10px; \/* Espa\u00e7amento superior opcional *\/\n        }\n        \n        .page-header-sub-text {\n            \/* Estilo para \"COMPARATIVO\" *\/\n            font-size: 20px;\n            color: #0396fe; \/* Cor azul do tema *\/\n            font-weight: 600;\n            letter-spacing: 1.5px;\n            text-transform: uppercase;\n        }\n        \n        .page-header-main-title {\n            \/* Estilo para \"Neuroterapia VS Terapias Convencionais\" *\/\n            font-size: 44px; \/* Tamanho grande *\/\n            color: #333333; \/* Cor escura do texto principal da imagem *\/\n            font-weight: 700; \/* Bold *\/\n            line-height: 1.1;\n            margin: 0;\n        }\n\n        \/* Removendo a linha azul inferior da antiga .section-title:after *\/\n        \/* A classe .section-title original ser\u00e1 mantida, mas estar\u00e1 vazia no HTML. *\/\n        .section-title {\n            display: none; \/* Esconde a antiga .section-title se for usada por engano *\/\n        }\n\n        \/* ---------------------------------------------------- *\/\n        \/* FIM NOVOS ESTILOS *\/\n        \/* ---------------------------------------------------- *\/\n\n        \/* Hiding old horizontal tabs completely *\/\n        .pain-tabs {\n            display: none; \/* Forced hide of old horizontal tabs *\/\n        }\n\n        \/* Mobile Dropdown Styles - Now the primary navigation *\/\n        .mobile-dropdown {\n            display: block; \/* Show on all devices (Desktop & Mobile) *\/\n            position: relative;\n            width: 100%;\n            max-width: 550px; \/* Constraint width on desktop and center it *\/\n            margin: 0 auto 30px auto;\n        }\n\n        \/* DROPDOWN TRIGGER (TOP BUTTON) - KEEPING ROUNDED STYLE *\/\n        .dropdown-trigger {\n            width: 100%;\n            padding: 18px 25px;\n            background-color: #0396fe;\n            color: white;\n            border: none;\n            border-radius: 50px; \/* MANTIDO ARREDONDADO *\/\n            font-size: 17px;\n            font-weight: 600;\n            cursor: pointer;\n            display: flex;\n            justify-content: space-between;\n            align-items: center;\n            box-shadow: 0 4px 8px rgba(3, 150, 254, 0.2);\n            transition: all 0.3s ease;\n        }\n\n        .dropdown-trigger:hover {\n            background-color: #0358aa;\n        }\n        \n        \/* NOVOS ESTILOS PARA O INDICADOR DE MENU *\/\n        \/* Contentor para organizar o texto MENU e a seta *\/\n        .menu-indicator {\n            display: flex;\n            flex-direction: column; \/* Coloca os elementos (texto e seta) um por cima do outro *\/\n            align-items: center; \/* Centra horizontalmente o texto e a seta *\/\n            line-height: 1; \/* Ajusta o espa\u00e7amento vertical entre a linha de base dos elementos *\/\n        }\n\n        \/* Estilo para o texto \"MENU\" *\/\n        .menu-text {\n            font-size: 10px; \/* Tamanho pequeno para o texto *\/\n            font-weight: 700; \/* Negrito *\/\n            color: white; \/* Cor branca para contraste no bot\u00e3o azul *\/\n            margin-bottom: 2px; \/* Espa\u00e7o entre o texto e a seta *\/\n            letter-spacing: 0.5px; \/* Espa\u00e7amento entre as letras *\/\n            text-transform: uppercase; \/* Garantir que est\u00e1 em mai\u00fasculas *\/\n        }\n        \/* FIM NOVOS ESTILOS *\/\n\n        .dropdown-arrow {\n            transition: transform 0.3s ease;\n            font-size: 20px;\n            line-height: 1; \/* Adicionado para ajudar a centralizar melhor a seta no novo indicador *\/\n        }\n\n        .dropdown-trigger.active .dropdown-arrow {\n            transform: rotate(180deg);\n        }\n\n        \/* DROPDOWN MENU - MODIFICADO para RETANGULAR e cor de fundo para ser a mesma do item *\/\n        .dropdown-menu {\n            position: absolute;\n            top: calc(100% + 10px);\n            left: 0;\n            right: 0;\n            \/* Cor de fundo para que n\u00e3o haja bordas brancas laterais - Usamos a cor do item ativo *\/\n            background: #0396fe; \n            border-radius: 0; \/* REMOVIDO ARREDONDAMENTO *\/\n            box-shadow: 0 10px 30px rgba(0,0,0,0.15); \/* MANTIDO sombra *\/\n            opacity: 0;\n            visibility: hidden;\n            transform: translateY(-10px);\n            transition: all 0.3s ease;\n            z-index: 100;\n            max-height: 80vh; \n            overflow-y: auto; \n            overflow-x: hidden; \n            padding: 0; \/* Remover padding que pode causar espa\u00e7o em branco *\/\n            margin: 0; \/* Remover margin que pode causar espa\u00e7o em branco *\/\n        }\n\n        .dropdown-menu.show {\n            opacity: 1;\n            visibility: visible;\n            transform: translateY(0);\n        }\n\n        \/* DROPDOWN ITEM - MODIFICADO para RETANGULAR e cor de fundo padr\u00e3o BRANCA *\/\n        .dropdown-item {\n            padding: 15px 25px;\n            border: none;\n            background: white; \/* Cor de fundo Padr\u00e3o (Item Inativo) *\/\n            width: 100%;\n            text-align: left;\n            font-size: 16px;\n            font-weight: 600;\n            color: #555;\n            cursor: pointer;\n            transition: all 0.2s ease;\n            border-bottom: 1px solid #f0f0f0;\n            border-radius: 0; \/* REMOVIDO ARREDONDAMENTO *\/\n            \/* Garante que o item preenche completamente o contentor *\/\n            display: block; \n            box-sizing: border-box;\n        }\n\n        .dropdown-item:last-child {\n            border-bottom: none;\n        }\n\n        \/* MODIFICADO: Item ATIVO e em HOVER preenchido a azul e texto branco *\/\n        .dropdown-item.active,\n        .dropdown-item:hover {\n            background-color: #0396fe; \/* Cor Azul Principal para preenchimento total *\/\n            color: white; \/* Texto Branco *\/\n            padding-left: 25px; \/* MANTIDO padding original *\/\n        }\n        \n        \/* O item de DEPRESS\u00c3O (primeiro item) est\u00e1 com um arredondamento indesejado no topo.\n           Isto \u00e9 causado pelo primeiro item estar em \"active\" por predefini\u00e7\u00e3o.\n           Vamos garantir que o primeiro item do menu dropwdown n\u00e3o tem borda arredondada.\n        *\/\n        .dropdown-menu .dropdown-item:first-child {\n             border-top-left-radius: 0;\n             border-top-right-radius: 0;\n        }\n\n        \/* Remove a sombra da caixa dos items - Opcional, mas pode ajudar na limpeza visual *\/\n        .pain-content {\n            display: none;\n            background: white;\n            padding: 30px;\n            border-radius: 10px;\n            box-shadow: 0 5px 15px rgba(0,0,0,0.05);\n            margin-bottom: 20px;\n        }\n        \n        \/* ... (Resto do CSS inalterado) ... *\/\n        \n        .pain-content.active {\n            display: block;\n            animation: fadeIn 0.5s ease-in-out;\n        }\n\n        @keyframes fadeIn {\n            from { opacity: 0; transform: translateY(10px); }\n            to { opacity: 1; transform: translateY(0); }\n        }\n\n        .pain-header {\n            margin-bottom: 25px;\n        }\n\n        .pain-header h3 {\n            color: #0396fe;\n            font-size: 24px;\n            margin-bottom: 10px;\n        }\n\n        .pain-header p {\n            color: #666;\n            font-size: 16px;\n            line-height: 1.6;\n        }\n\n        .treatment-comparison {\n            margin: 30px 0;\n        }\n\n        .treatment-bar {\n            margin-bottom: 20px;\n        }\n\n        .bar-label {\n            display: block;\n            font-size: 17px;\n            font-weight: 600;\n            margin-bottom: 8px;\n            color: #444;\n        }\n\n        .bar-container {\n            height: 40px;\n            background-color: #f1f1f1;\n            border-radius: 20px;\n            position: relative;\n            overflow: hidden;\n            box-shadow: inset 0 1px 3px rgba(0,0,0,0.1);\n        }\n\n        .bar-legend-container {\n            display: flex;\n            justify-content: flex-start;\n            flex-wrap: wrap;\n            margin-top: 8px;\n            font-size: 13px;\n        }\n\n        .legend-item {\n            display: flex;\n            align-items: center;\n            margin-right: 15px;\n            color: #555;\n        }\n\n        .legend-color {\n            width: 12px;\n            height: 12px;\n            border-radius: 2px;\n            margin-right: 5px;\n            flex-shrink: 0;\n        }\n\n        .legend-green {\n            background-color: #4CAF50;\n        }\n\n        .legend-blue {\n            background-color: #0396fe;\n        }\n\n        .legend-red {\n            background-color: #E53935;\n        }\n\n        .legend-gold { \/* New legend color *\/\n             background: linear-gradient(135deg, #FFFACD, #DAA520);\n        }\n\n\n        .bar {\n            height: 100%;\n            position: absolute;\n            border-radius: 20px;\n            transition: width 1.5s ease-in-out;\n            width: 0;\n            left: 0;\n        }\n\n        .bar-green {\n            background-color: #4CAF50;\n            box-shadow: inset 0 -2px 0 rgba(0,0,0,0.15);\n            z-index: 1;\n        }\n\n        .bar-blue {\n            background-color: #0396fe;\n            background-image: linear-gradient(135deg, #0396fe, #0358aa);\n            box-shadow: inset 0 -2px 0 rgba(0,0,0,0.15);\n            z-index: 0;\n        }\n\n        .bar-red {\n            background-color: #E53935;\n            box-shadow: inset 0 -2px 0 rgba(0,0,0,0.15);\n            z-index: 0;\n        }\n\n         \/* NEW: Gold bar style *\/\n        .bar-gold {\n            background-color: #DAA520; \/* Fallback *\/\n            background-image: linear-gradient(135deg, #FFFACD 0%, #F0E68C 30%, #DAA520 60%, #B8860B 100%);\n            box-shadow: inset 0 -2px 2px rgba(0, 0, 0, 0.2), inset 0 1px 1px rgba(255, 255, 255, 0.3);\n            z-index: 0;\n        }\n\n\n        \/* Base style for text overlays *\/\n        .bar-text-overlay {\n            position: absolute;\n            height: 100%;\n            color: white;\n            font-weight: 600;\n            font-size: 16px;\n            white-space: nowrap;\n            text-shadow: 0 0 3px rgba(0, 0, 0, 0.5);\n            overflow: hidden;\n            line-height: 40px; \/* Vertically center *\/\n            padding: 0 10px; \/* Add some padding *\/\n            box-sizing: border-box; \/* Include padding in width *\/\n        }\n\n        \/* Text specifically for Green bar *\/\n        .bar-text-green {\n            left: 0;\n            z-index: 2;\n            transition: width 1.5s ease-in-out;\n            width: 0;\n            text-align: right;\n        }\n\n        \/* Text specifically for Blue bar segment *\/\n        .bar-text-blue {\n            \/* left is set by JS *\/\n            z-index: 3;\n            transition: left 1.5s ease-in-out, width 1.5s ease-in-out;\n            width: 0;\n            left: 0; \/* Initial *\/\n            text-align: right;\n        }\n\n        \/* Text specifically for Red bar *\/\n        .bar-text-red {\n            left: 0;\n            z-index: 3;\n            transition: width 1.5s ease-in-out;\n            width: 0;\n            text-align: right;\n        }\n\n         \/* NEW: Text specifically for Gold bar *\/\n        .bar-text-gold {\n            left: 0;\n            z-index: 3;\n            transition: width 1.5s ease-in-out;\n            width: 0;\n            text-align: right;\n            color: white;       \/* ALTERADO para branco *\/\n            text-shadow: 0 0 3px rgba(0, 0, 0, 0.7); \/* ALTERADO para sombra mais escura (opcional, para contraste) *\/\n        }\n\n        \/* NEW: Important Info Box Style *\/\n        .important-info {\n            background-color: #fffbea; \/* Light yellow background *\/\n            border: 1px solid #fce08d;  \/* Yellow border *\/\n            border-left: 4px solid #fdbc4b; \/* Stronger yellow\/gold left border *\/\n            padding: 15px 20px;\n            margin-top: 30px; \/* Consistent top margin *\/\n            border-radius: 0 5px 5px 0; \/* Match other box styles *\/\n        }\n\n        .important-info h4 {\n            color: #c59120; \/* Darker yellow\/gold color for title *\/\n            margin-bottom: 10px;\n            font-size: 18px;\n            font-weight: 600; \/* Bolder title *\/\n        }\n\n        .important-info p {\n            color: #555;\n            font-size: 16px;\n            line-height: 1.6;\n        }\n        \/* END NEW: Important Info Box Style *\/\n\n        .treatment-description {\n            background-color: #f8fbff;\n            border-left: 4px solid #0396fe;\n            padding: 15px 20px;\n            margin-top: 30px;\n            border-radius: 0 5px 5px 0;\n        }\n\n        .treatment-description h4 {\n            color: #0396fe;\n            margin-bottom: 10px;\n            font-size: 18px;\n        }\n\n        .treatment-description p {\n            color: #555;\n            font-size: 16px;\n            line-height: 1.6;\n        }\n\n        .info-box {\n            display: flex;\n            gap: 20px;\n            margin-top: 30px;\n            flex-wrap: wrap;\n        }\n\n        .info-item {\n            flex: 1;\n            min-width: 250px;\n            background: #f8fbff;\n            padding: 20px;\n            border-radius: 8px;\n            box-shadow: 0 3px 8px rgba(0,0,0,0.05);\n        }\n\n        .info-item h4 {\n            color: #0396fe;\n            margin-bottom: 10px;\n            font-size: 18px;\n            display: flex;\n            align-items: center;\n        }\n\n        .info-item h4 i {\n            margin-right: 8px;\n        }\n\n        .info-item p {\n            color: #555;\n            font-size: 15px;\n        }\n\n        .action-btn {\n            display: block;\n            width: 100%;\n            padding: 16px 30px;\n            background-color: #0396fe;\n            color: white !important;\n            text-align: center;\n            font-size: 18px;\n            font-weight: 600;\n            border: none;\n            border-radius: 50px;\n            cursor: pointer;\n            margin-top: 40px;\n            transition: all 0.3s;\n            box-shadow: 0 4px 10px rgba(3, 150, 254, 0.3);\n            text-decoration: none;\n        }\n\n        .action-btn:hover {\n            background-color: #0358aa;\n            box-shadow: 0 6px 15px rgba(3, 150, 254, 0.4);\n            transform: translateY(-2px);\n            color: white;\n        }\n\n        \/* NOVO ESTILO BASE PARA O BOT\u00c3O \"VER ARTIGO\" *\/\n        .secondary-action-btn {\n            padding: 16px 30px;\n            background-color: white; \/* Fundo branco *\/\n            color: #0396fe !important; \/* Texto azul *\/\n            text-align: center;\n            font-size: 18px;\n            font-weight: 600;\n            border: 2px solid #0396fe; \/* Contorno azul *\/\n            border-radius: 50px;\n            cursor: pointer;\n            margin-top: 30px; \/* Espa\u00e7amento acima (Para quando \u00e9 usado isolado) *\/\n            margin-bottom: 20px; \/* Espa\u00e7amento abaixo (Para quando \u00e9 usado isolado) *\/\n            transition: all 0.3s;\n            box-shadow: 0 4px 10px rgba(3, 150, 254, 0.1);\n            text-decoration: none;\n            display: block; \/* Por defeito \u00e9 um bloco, mas ser\u00e1 ajustado no novo bloco *\/\n            width: 100%; \/* Por defeito, ocupa a largura total (Para quando \u00e9 usado isolado) *\/\n        }\n\n        .secondary-action-btn:hover {\n            background-color: #f0f8ff; \/* Azul claro ao passar o rato *\/\n            box-shadow: 0 6px 15px rgba(3, 150, 254, 0.2);\n            transform: translateY(-1px);\n            color: #0358aa !important; \/* Azul mais escuro no hover *\/\n            border-color: #0358aa;\n        }\n        \n        \/* ---------------------------------------------------- *\/\n        \/* NOVO BLOCO: IMAGEM + TEXTO + BOT\u00c3O (Ver Artigo) *\/\n        \/* ---------------------------------------------------- *\/\n        .article-callout {\n            display: flex;\n            align-items: center; \/* Harmonization: center vertically *\/\n            gap: 30px;\n            margin-top: 40px; \/* Separator from previous content *\/\n            padding: 25px;\n            background-color: #f0faff; \/* Very light blue background to highlight *\/\n            border: 1px solid #d0e8ff;\n            border-radius: 10px;\n            box-shadow: 0 4px 10px rgba(0, 0, 0, 0.08);\n        }\n\n        .article-callout-image-wrapper {\n            flex-shrink: 0; \n            width: 150px; \/* Small size for the image\/placeholder *\/\n            position: relative; \n            padding-bottom: calc(150px * 2 \/ 3); \/* 3:2 aspect ratio *\/\n            overflow: hidden;\n            border-radius: 6px;\n            \/* Estilos de Placeholder removidos\/alterados *\/\n            background-color: transparent; \n            border: 1px solid #ccc; \/* Pode manter uma borda cinza clara se desejar *\/\n        }\n        \n        \/* REMO\u00c7\u00c3O do texto de placeholder *\/\n        .article-callout-image-wrapper::before {\n            content: none; \n        }\n\n        \/* NOVO CSS PARA A IMAGEM REAL: For\u00e7a a imagem a preencher o contentor 3:2 *\/\n        .article-callout-image-wrapper img {\n            position: absolute; \/* Essencial para preencher o contentor que usa padding-bottom para a altura *\/\n            top: 0;\n            left: 0;\n            width: 100%;\n            height: 100%;\n            object-fit: cover; \/* Garante que a imagem preenche a \u00e1rea sem ser distorcida, cortando se necess\u00e1rio *\/\n            border-radius: 6px;\n        }\n        \n        \/* FIM NOVO CSS PARA A IMAGEM REAL *\/\n        \n        .article-callout-content {\n            flex-grow: 1; \/* Allows the content to take remaining space *\/\n        }\n\n        .article-callout-title {\n            color: #0358aa;\n            font-size: 20px;\n            margin-bottom: 5px;\n            font-weight: 700;\n        }\n\n        .article-callout-description {\n            color: #555;\n            font-size: 16px;\n            margin-bottom: 15px;\n            line-height: 1.4;\n        }\n\n        \/* Ajustar o bot\u00e3o dentro do bloco para harmoniza\u00e7\u00e3o *\/\n        .article-callout .secondary-action-btn {\n            width: auto; \/* Bot\u00e3o mais estreito para n\u00e3o ocupar 100% da coluna *\/\n            max-width: 250px; \n            display: inline-block; \n            padding: 12px 25px; \/* Padding ligeiramente menor *\/\n            font-size: 16px;\n            margin-top: 0; \n            margin-bottom: 0; \n        }\n\n        \/* ---------------------------------------------------- *\/\n        \/* FIM NOVO BLOCO *\/\n        \/* ---------------------------------------------------- *\/\n\n\n        .bar-legend {\n            display: block;\n            font-size: 14px;\n            color: #666;\n            margin-top: 5px;\n            font-style: italic;\n        }\n\n        .comparison-section {\n            margin-top: 30px;\n            margin-bottom: 30px;\n        }\n\n        .comparison-title {\n            font-weight: 600;\n            color: #444;\n            margin-bottom: 20px;\n            font-size: 18px;\n            text-align: center;\n        }\n\n        \/* Responsive styles *\/\n        @media (max-width: 768px) {\n            \n             .pain-tabs {\n                display: none;\n            }\n            \n            .mobile-dropdown {\n                max-width: 100%; \/* Use full width on mobile *\/\n            }\n\n            .pain-content {\n                padding: 20px;\n            }\n\n            .treatment-bar {\n                margin-bottom: 15px;\n            }\n\n            .bar-text-overlay {\n                font-size: 14px;\n                line-height: 40px;\n                padding: 0 5px;\n            }\n\n            .bar-label {\n                font-size: 15px;\n            }\n\n            .info-item {\n                flex: 1 1 100%;\n            }\n\n             \/* Responsive adjustments for the new Article Callout block *\/\n            .article-callout {\n                flex-direction: column;\n                text-align: center;\n                padding: 20px;\n            }\n            \n            .article-callout-image-wrapper {\n                width: 100%;\n                max-width: 200px; \n                margin-bottom: 10px;\n                padding-bottom: calc(200px * 2 \/ 3); \n            }\n            \n            .article-callout-content {\n                text-align: center;\n            }\n\n             .article-callout .secondary-action-btn {\n                width: 100%; \n                max-width: none;\n                margin-top: 10px;\n            }\n        }\n\n        @media (max-width: 480px) {\n            \n            .page-header-main-title {\n                font-size: 32px; \/* Ajuste para mobile *\/\n            }\n            \n             .section-title {\n                font-size: 24px;\n            }\n\n            .pain-header h3 {\n                font-size: 20px;\n            }\n             .bar-text-overlay {\n                font-size: 12px;\n             }\n        }\n    <\/style>\n<\/head>\n<body>\n    <div class=\"container\">\n        <!-- T\u00cdTULO ATUALIZADO PARA CORRESPONDER \u00c0 IMAGEM -->\n        <div class=\"page-header-container\">\n            <p class=\"page-header-sub-text\">COMPARATIVO<\/p>\n            <h2 class=\"page-header-main-title\">Neuroterapia <br> VS Terapias convencionales<\/h2>\n        <\/div>\n        \n        <!-- Mobile Dropdown - Now the main navigation (Desktop & Mobile) -->\n        <div class=\"mobile-dropdown\">\n            <button class=\"dropdown-trigger\" id=\"dropdownTrigger\">\n                <span id=\"selectedOption\">Depresi\u00f3n<\/span>\n                <!-- NOVO BLOCO: Indicador de Menu com texto MENU + Seta -->\n                <div class=\"menu-indicator\">\n                    <span class=\"menu-text\">MEN\u00da<\/span>\n                    <span class=\"dropdown-arrow\">\u25bc<\/span>\n                <\/div>\n                <!-- FIM NOVO BLOCO -->\n            <\/button>\n            <div class=\"dropdown-menu\" id=\"dropdownMenu\">\n                <!-- Existing 5 -->\n                <button class=\"dropdown-item active\" data-tab=\"depressao\">Depresi\u00f3n<\/button>\n                <button class=\"dropdown-item\" data-tab=\"dor-neuropatica\">Dolor neurop\u00e1tico<\/button>\n                <button class=\"dropdown-item\" data-tab=\"enxaqueca\">Migra\u00f1a<\/button>\n                <button class=\"dropdown-item\" data-tab=\"fibromialgia\">Fibromialgia<\/button>\n                <button class=\"dropdown-item\" data-tab=\"insonia\">Insomnio<\/button>\n                <!-- NEW 5 Pathologies -->\n                <button class=\"dropdown-item\" data-tab=\"tdah\">TDAH<\/button>\n                <button class=\"dropdown-item\" data-tab=\"tabagismo\">Fumar<\/button>\n                <button class=\"dropdown-item\" data-tab=\"stress-post-traumatico\">Estr\u00e9s postraum\u00e1tico<\/button>\n                <button class=\"dropdown-item\" data-tab=\"pos-avc\">Despu\u00e9s de la apoplej\u00eda<\/button>\n                <button class=\"dropdown-item\" data-tab=\"toc\">TOC<\/button>\n            <\/div>\n        <\/div>\n\n\n        <!-- Conte\u00fado Existente: Depress\u00e3o -->\n        <div class=\"pain-content active\" id=\"depressao\">\n            <!-- ... Conte\u00fado Existente da Depress\u00e3o ... -->\n             <div class=\"pain-header\">\n                <h3>Depresi\u00f3n<\/h3>\n                <p>La depresi\u00f3n afecta significativamente a la calidad de vida, causando sufrimiento mental y f\u00edsico. Compare la eficacia de los tratamientos convencionales con nuestros avanzados enfoques neurol\u00f3gicos.<\/p>\n            <\/div>\n\n            <div class=\"treatment-comparison\">\n                <div class=\"comparison-title\">Eficacia general de los tratamientos<\/div>\n                <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"15%\"><\/div>\n                        <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"27.5%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"15%\">15%<\/div>\n                        <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"27.5%\">27.5%<\/div> <!-- Corrigido , por . -->\n                    <\/div>\n                    <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejora de los s\u00edntomas, con 1 a 4 etapas de tratamiento <\/span>\n                    <div class=\"bar-legend-container\">\n                        <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div>\n                        <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div>\n                    <\/div>\n                <\/div>\n\n                <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"38%\"><\/div>\n                        <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"71%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"38%\">38%<\/div>\n                        <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"71%\">71%<\/div>\n                    <\/div>\n                    <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejora de los s\u00edntomas con EMT, tras s\u00f3lo 1 ciclo completo de tratamiento.<\/span>\n                    <div class=\"bar-legend-container\">\n                        <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div>\n                        <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n\n            <div class=\"treatment-comparison\">\n                <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n                <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"95%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"95%\">95%<\/div>\n                    <\/div>\n                    <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios significativos<\/span>\n                <\/div>\n\n                <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"4%\">4%<\/div>\n                    <\/div>\n                    <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n                <\/div>\n            <\/div>\n\n            <!-- NEW: Gold Bar Section -->\n            <div class=\"treatment-comparison\">\n                <div class=\"comparison-title\">Mejora convencional tras un fallo<\/div>\n                 <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">TMS (Postfallo convencional)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"58%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"58%\">58%<\/div>\n                    <\/div>\n                    <span class=\"bar-legend\">Porcentaje de pacientes con mejor\u00eda significativa tras el fracaso de \u22652 tratamientos convencionales<\/span>\n                     <div class=\"bar-legend-container\">\n                        <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora significativa<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            <!-- End Gold Bar Section -->\n\n            <!-- Sec\u00e7\u00e3o Importante -->\n            <div class=\"important-info\">\n                <h4>Importante<\/h4>\n                <p>Es importante se\u00f1alar que las mejoras s\u00f3lo se refieren a los s\u00edntomas directos de la depresi\u00f3n, y no se tiene en cuenta el estado cl\u00ednico general del paciente. Los efectos secundarios no se tienen en cuenta en los \u00edndices de mejor\u00eda, siempre que no impidan la mejor\u00eda de los s\u00edntomas de la depresi\u00f3n. Terapias como la EMT\/EMT satisfacen la necesidad de tratar la enfermedad junto con el paciente, en lugar de tratar la enfermedad en detrimento de su bienestar general. Esta p\u00e1gina contiene informaci\u00f3n relevante sobre la depresi\u00f3n y los tratamientos que se ofrecen. Es fundamental que comente su caso concreto con un profesional sanitario. <\/p>\n            <\/div>\n            <!-- Fim da Sec\u00e7\u00e3o Importante -->\n\n            <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La estimulaci\u00f3n magn\u00e9tica transcraneal (EMT) utiliza campos magn\u00e9ticos focalizados para estimular zonas espec\u00edficas del cerebro asociadas a la depresi\u00f3n. Este tratamiento no invasivo demuestra una eficacia superior a la de los f\u00e1rmacos antidepresivos, sobre todo en casos resistentes a los tratamientos convencionales. La EMT no tiene los efectos secundarios habituales de la medicaci\u00f3n, como aumento de peso, disfunci\u00f3n sexual o somnolencia.<\/p><\/div><div class=\"info-box\"><div class=\"info-item\"><h4><i>\u2713<\/i> Resultados r\u00e1pidos<\/h4><p>Muchos pacientes informan de las primeras mejoras en las primeras semanas de tratamiento, mientras que la medicaci\u00f3n puede tardar entre 5 y 7 semanas.<\/p><\/div><div class=\"info-item\"><h4><i>\u2713<\/i> Duraci\u00f3n del efecto<\/h4><p>Los efectos positivos de la EMT pueden durar de 6 meses a 1 a\u00f1o despu\u00e9s del tratamiento, con sesiones peri\u00f3dicas de mantenimiento. En muchos casos, utilizando enfoques psicoterap\u00e9uticos, es posible lograr la remisi\u00f3n completa de los s\u00edntomas<\/p><\/div><\/div>\n        <\/div>\n        \n        <!-- Conte\u00fado Existente: Dor Neurop\u00e1tica (COM ALTERA\u00c7\u00c3O) -->\n        <div class=\"pain-content\" id=\"dor-neuropatica\">\n             <div class=\"pain-header\"><h3>Dolor neurop\u00e1tico<\/h3><p>El dolor neurop\u00e1tico es consecuencia de lesiones o disfunciones del sistema nervioso y suele ser resistente a los analg\u00e9sicos convencionales. Compare la eficacia de los tratamientos.<\/p><\/div>\n             <div class=\"treatment-comparison\">\n                 <div class=\"comparison-title\">Eficacia general de los tratamientos<\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                         <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"19%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"3%\">3%<\/div>\n                         <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"19%\">19%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y \u226550% de mejora del dolor en todas las fases del tratamiento<\/span>\n                     <div class=\"bar-legend-container\"><div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div><div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div><\/div>\n                 <\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Estimulaci\u00f3n transcraneal por corriente continua (tDCS)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                         <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"75%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"3%\">3%<\/div>\n                         <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"75%\">75%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y \u226550% de mejora del dolor tras s\u00f3lo 1 ciclo completo de tDCS<\/span>\n                     <div class=\"bar-legend-container\"><div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div><div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div><\/div>\n                 <\/div>\n             <\/div>\n             <div class=\"treatment-comparison\">\n                 <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"55%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"55%\">55%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios significativos<\/span>\n                 <\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Estimulaci\u00f3n transcraneal por corriente continua (tDCS)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"2%\">2%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n                 <\/div>\n             <\/div>\n             <!-- Gold Bar Section -->\n            <div class=\"treatment-comparison\">\n                <div class=\"comparison-title\">Mejora convencional tras un fallo<\/div>\n                 <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">tDCS (Post-fallo convencional)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"40%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"40%\">40%<\/div>\n                    <\/div>\n                    <span class=\"bar-legend\">Porcentaje de pacientes con mejor\u00eda significativa del dolor (\u226550%) tras el fracaso de los tratamientos convencionales.<\/span>\n                     <div class=\"bar-legend-container\">\n                        <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora significativa<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            <!-- End Gold Bar Section -->\n             <!-- Sec\u00e7\u00e3o Importante -->\n            <div class=\"important-info\">\n                <h4>Importante<\/h4>\n                <p> Cabe se\u00f1alar que estas estad\u00edsticas s\u00f3lo tienen en cuenta mejoras de m\u00e1s de 50% en la frecuencia e intensidad del dolor. Mejoras de 20, 30, 40% son extremadamente relevantes en el tratamiento de afecciones como el Dolor Neurop\u00e1tico. Esta secci\u00f3n contiene informaci\u00f3n de fondo relevante sobre el Dolor Neurop\u00e1tico y los tratamientos presentados. Es fundamental que comente su caso concreto con un profesional sanitario.<\/p>\n            <\/div>\n            <!-- Fim da Sec\u00e7\u00e3o Importante -->\n             <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La estimulaci\u00f3n transcraneal por corriente continua (tDCS) aplica una corriente el\u00e9ctrica de baja intensidad para modular la actividad neuronal en zonas espec\u00edficas del cerebro. Se ha demostrado que este tratamiento no invasivo reduce significativamente el dolor neurop\u00e1tico al ajustar los circuitos neuronales implicados en la percepci\u00f3n y el procesamiento del dolor, ofreciendo alivio all\u00ed donde fracasan los medicamentos convencionales.<\/p><\/div><div class=\"info-box\"><div class=\"info-item\"><h4><i>\u2713<\/i> Sin efectos secundarios significativos<\/h4><p>A diferencia de muchos medicamentos para el dolor neurop\u00e1tico, la tDCS no provoca sedaci\u00f3n, adicci\u00f3n ni toxicidad hep\u00e1tica.<\/p><\/div><div class=\"info-item\"><h4><i>\u2713<\/i> Trato personalizado<\/h4><p>La estimulaci\u00f3n puede ajustarse espec\u00edficamente a su tipo de dolor neurop\u00e1tico y a su localizaci\u00f3n, maximizando los resultados.<\/p><\/div><\/div>\n            <!-- NOVO BLOCO IMAGEM + TEXTO + BOT\u00c3O \"VER ARTIGO\" -->\n            <div class=\"article-callout\">\n                <div class=\"article-callout-image-wrapper\">\n                    <!-- Imagem 3:2: Coloque a sua tag <img> aqui. O novo CSS vai faz\u00ea-la caber. -->\n                    <img decoding=\"async\" src=\"https:\/\/neuropsiquiatria.pt\/wp-content\/uploads\/2025\/07\/ChatGPT-Image-5_07_2025-18_59_35.webp\" alt=\"Imagem Dor Neurop\u00e1tica\">\n                <\/div>\n                <div class=\"article-callout-content\">\n                    <h4 class=\"article-callout-title\">Consulte el art\u00edculo \"La gu\u00eda completa: dolor neurop\u00e1tico\"<\/h4>\n                    <p class=\"article-callout-description\">Todo lo que necesita saber para comprender el dolor neurop\u00e1tico.<\/p>\n                    <a href=\"https:\/\/neuropsiquiatria.pt\/es\/dor-neuropatica-o-guia-completo-2025\/\" class=\"secondary-action-btn article-callout-btn\">Ver art\u00edculo<\/a>\n                <\/div>\n            <\/div>\n        <\/div>\n\n        <!-- Conte\u00fado Existente: Enxaqueca (COM ALTERA\u00c7\u00c3O) -->\n        <div class=\"pain-content\" id=\"enxaqueca\">\n             <div class=\"pain-header\"><h3>Migra\u00f1a<\/h3><p>Las migra\u00f1as pueden ser debilitantes y afectar significativamente a la calidad de vida. Compare la eficacia de los tratamientos convencionales con nuestros avanzados enfoques neurol\u00f3gicos.<\/p><\/div>\n             <div class=\"treatment-comparison\">\n                 <div class=\"comparison-title\">Eficacia general de los tratamientos<\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"20%\"><\/div>\n                         <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"45%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"20%\">20%<\/div>\n                         <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"45%\">45%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y reducci\u00f3n de la frecuencia de episodios mensuales (\u226550%) con medicaci\u00f3n profil\u00e1ctica preventiva.<\/span>\n                     <div class=\"bar-legend-container\"><div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div><div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div><\/div>\n                 <\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"27%\"><\/div>\n                         <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"45%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"27%\">27%<\/div>\n                         <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"45%\">45%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y reducci\u00f3n de la frecuencia de episodios mensuales (\u226550%) tras 1 ciclo completo de EMT.<\/span>\n                     <div class=\"bar-legend-container\"><div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div><div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div><\/div>\n                 <\/div>\n             <\/div>\n             <div class=\"treatment-comparison\">\n                 <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"70%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"70%\">70%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios significativos<\/span>\n                 <\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"3%\">3%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n                 <\/div>\n             <\/div>\n              <!-- Gold Bar Section -->\n            <div class=\"treatment-comparison\">\n                <div class=\"comparison-title\">Mejora convencional tras un fallo<\/div>\n                 <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">TMS (Postfallo convencional)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"72%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"72%\">72%<\/div>\n                    <\/div>\n                    <span class=\"bar-legend\">Porcentaje de pacientes con una reducci\u00f3n significativa (\u226550%) de la frecuencia de convulsiones tras el fracaso de los tratamientos profil\u00e1cticos convencionales.<\/span>\n                     <div class=\"bar-legend-container\">\n                        <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora significativa<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            <!-- End Gold Bar Section -->\n             <!-- Sec\u00e7\u00e3o Importante -->\n            <div class=\"important-info\">\n                <h4>Importante<\/h4>\n                <p>Es importante se\u00f1alar que los datos presentados se refieren \u00fanicamente a la reducci\u00f3n de la frecuencia de los episodios (MMD). La EMT\/TMS tambi\u00e9n afecta a la intensidad del dolor. Esta secci\u00f3n contiene informaci\u00f3n b\u00e1sica relevante sobre la migra\u00f1a y los tratamientos presentados. Es fundamental que consulte su caso concreto con un profesional sanitario.<\/p>\n            <\/div>\n            <!-- Fim da Sec\u00e7\u00e3o Importante -->\n             <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La EMT para las migra\u00f1as se centra en las \u00e1reas cerebrales implicadas en los procesos dolorosos y migra\u00f1osos. Este tratamiento no farmacol\u00f3gico ha demostrado su eficacia tanto en la prevenci\u00f3n como en el tratamiento de las crisis agudas, reduciendo la frecuencia, intensidad y duraci\u00f3n de las migra\u00f1as en pacientes que no responden a los tratamientos convencionales.<\/p><\/div><div class=\"info-box\"><div class=\"info-item\"><h4><i>\u2713<\/i> Reducci\u00f3n de frecuencia<\/h4><p>Los pacientes informan de una reducci\u00f3n media de 45% en la frecuencia de migra\u00f1as tras un ciclo completo de tratamiento.<\/p><\/div><div class=\"info-item\"><h4><i>\u2713<\/i> Alivio a largo plazo<\/h4><p>Muchos pacientes mantienen los beneficios durante 3-6 meses tras finalizar el ciclo de tratamiento. En algunos casos, es posible la remisi\u00f3n temporal completa de los s\u00edntomas o incluso la remisi\u00f3n definitiva.<\/p><\/div><\/div>\n            <!-- NOVO BLOCO IMAGEM + TEXTO + BOT\u00c3O \"VER ARTIGO\" -->\n            <div class=\"article-callout\">\n                <div class=\"article-callout-image-wrapper\">\n                    <!-- Imagem 3:2: Coloque a sua tag <img> aqui. O novo CSS vai faz\u00ea-la caber. -->\n                    <img decoding=\"async\" src=\"https:\/\/neuropsiquiatria.pt\/wp-content\/uploads\/2025\/10\/imagem-capa-enxaqueca.webp\" alt=\"Imagem Enxaqueca\">\n                <\/div>\n                <div class=\"article-callout-content\">\n                    <h4 class=\"article-callout-title\">Consulte el art\u00edculo \"La gu\u00eda completa: migra\u00f1a\"<\/h4>\n                    <p class=\"article-callout-description\">Todo lo que necesita saber para entender la migra\u00f1a.<\/p>\n                    <a href=\"https:\/\/neuropsiquiatria.pt\/es\/enxaqueca-o-guia-completo-2025\/\" class=\"secondary-action-btn article-callout-btn\">Ver art\u00edculo<\/a>\n                <\/div>\n            <\/div>\n        <\/div>\n\n        <!-- Conte\u00fado Existente: Fibromialgia (COM ALTERA\u00c7\u00c3O) -->\n        <div class=\"pain-content\" id=\"fibromialgia\">\n             <div class=\"pain-header\"><h3>Fibromialgia<\/h3><p>La fibromialgia se caracteriza por dolor generalizado y sensibilidad en m\u00faltiples puntos del cuerpo, y suele ser resistente a los tratamientos convencionales.<\/p><\/div>\n             <div class=\"treatment-comparison\">\n                 <div class=\"comparison-title\">Eficacia general de los tratamientos<\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                         <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"22%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"2%\">2%<\/div>\n                         <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"22%\">22%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejora significativa del dolor (\u226550%) tras 6 meses de tratamiento farmacol\u00f3gico.<\/span>\n                     <div class=\"bar-legend-container\"><div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div><div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div><\/div>\n                 <\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Enfoque combinado (EMT + tDCS)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                         <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"40%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"2%\">2%<\/div>\n                         <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"40%\">40%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejora significativa del dolor (\u226550%) tras protocolo combinado (EMT+tDCS)<\/span>\n                     <div class=\"bar-legend-container\"><div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div><div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div><\/div>\n                 <\/div>\n             <\/div>\n             <div class=\"treatment-comparison\">\n                 <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"80%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"80%\">80%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios significativos<\/span>\n                 <\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Enfoque combinado (EMT + tDCS)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"4%\">4%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n                 <\/div>\n             <\/div>\n            <!-- Gold Bar Section -->\n            <div class=\"treatment-comparison\">\n                <div class=\"comparison-title\">Mejora convencional tras un fallo<\/div>\n                 <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">Enfoque combinado (post-fracaso convencional)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"48%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"48%\">48%<\/div>\n                    <\/div>\n                    <span class=\"bar-legend\">Porcentaje de pacientes con mejor\u00eda significativa (\u226550%) del dolor, la fatiga, el sue\u00f1o, tras el fracaso de los tratamientos convencionales.<\/span>\n                    <div class=\"bar-legend-container\">\n                        <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora significativa<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            <!-- End Gold Bar Section -->\n            <!-- Sec\u00e7\u00e3o Importante -->\n            <div class=\"important-info\">\n                <h4>Importante<\/h4>\n                <p>Esta secci\u00f3n contiene informaci\u00f3n b\u00e1sica relevante sobre la fibromialgia y los tratamientos presentados. Es fundamental que comente su caso concreto con un profesional sanitario.<\/p>\n            <\/div>\n            <!-- Fim da Sec\u00e7\u00e3o Importante -->\n             <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>El enfoque combinado de EMT y tDCS pretende modular las v\u00edas del dolor y mejorar el procesamiento sensorial da\u00f1ado en la fibromialgia. Este protocolo espec\u00edfico muestra resultados superiores a los f\u00e1rmacos convencionales, reduciendo el dolor generalizado, mejorando la calidad del sue\u00f1o y reduciendo la fatiga asociada a la fibromialgia.<\/p><\/div><div class=\"info-box\"><div class=\"info-item\"><h4><i>\u2713<\/i> Alivio integral<\/h4><p>El tratamiento no s\u00f3lo reduce el dolor, sino que tambi\u00e9n mejora otros s\u00edntomas como la fatiga, los trastornos del sue\u00f1o y la claridad mental.<\/p><\/div><div class=\"info-item\"><h4><i>\u2713<\/i> Reducir el uso de medicamentos<\/h4><p>M\u00e1s del 70% de los pacientes consiguen reducir su medicaci\u00f3n contra el dolor de forma muy significativa tras el tratamiento.<\/p><\/div><\/div>\n            <!-- NOVO BLOCO IMAGEM + TEXTO + BOT\u00c3O \"VER ARTIGO\" -->\n            <div class=\"article-callout\">\n                <div class=\"article-callout-image-wrapper\">\n                    <!-- Imagem 3:2: Coloque a sua tag <img> aqui. O novo CSS vai faz\u00ea-la caber. -->\n                    <img decoding=\"async\" src=\"https:\/\/neuropsiquiatria.pt\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-16_06_2025-03_37_29.png\" alt=\"Imagem Fibromialgia\">\n                <\/div>\n                <div class=\"article-callout-content\">\n                    <h4 class=\"article-callout-title\">Ver el art\u00edculo \"La gu\u00eda completa: Fibromialgia\"<\/h4>\n                    <p class=\"article-callout-description\">Todo lo que necesitas saber para entender la fibromialgia.<\/p>\n                    <a href=\"https:\/\/neuropsiquiatria.pt\/es\/fibromialgia-o-guia-completo-2025\/\" class=\"secondary-action-btn article-callout-btn\">Ver art\u00edculo<\/a>\n                <\/div>\n            <\/div>\n        <\/div>\n\n        <!-- Conte\u00fado Existente: Ins\u00f3nia (COM ALTERA\u00c7\u00c3O) -->\n        <div class=\"pain-content\" id=\"insonia\">\n             <div class=\"pain-header\"><h3>Insomnio<\/h3><p>El insomnio cr\u00f3nico afecta profundamente a la salud f\u00edsica y mental, contribuyendo al desarrollo de diversas afecciones y reduciendo la calidad de vida.<\/p><\/div>\n             <div class=\"treatment-comparison\">\n                 <div class=\"comparison-title\">Eficacia general de los tratamientos<\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"28%\"><\/div>\n                         <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"60%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"28%\">28%<\/div>\n                         <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"60%\">60%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes con normalizaci\u00f3n completa o mejora significativa del patr\u00f3n de sue\u00f1o tras 3 meses de medicaci\u00f3n.<\/span>\n                     <div class=\"bar-legend-container\"><div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div><div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div><\/div>\n                 <\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"35%\"><\/div>\n                         <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"70%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"35%\">35%<\/div>\n                         <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"70%\">70%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes con normalizaci\u00f3n completa o mejora significativa del patr\u00f3n de sue\u00f1o tras un ciclo completo de EMT.<\/span>\n                     <div class=\"bar-legend-container\"><div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div><div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div><\/div>\n                 <\/div>\n             <\/div>\n             <div class=\"treatment-comparison\">\n                 <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"77%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"77%\">77%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios significativos<\/span>\n                 <\/div>\n                 <div class=\"treatment-bar\">\n                     <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n                     <div class=\"bar-container\">\n                         <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"4%\"><\/div>\n                         <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"1%\">1%<\/div>\n                     <\/div>\n                     <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n                 <\/div>\n             <\/div>\n            <!-- Gold Bar Section -->\n            <div class=\"treatment-comparison\">\n                <div class=\"comparison-title\">Mejora convencional tras un fallo<\/div>\n                 <div class=\"treatment-bar\">\n                    <span class=\"bar-label\">TMS (Postfallo convencional)<\/span>\n                    <div class=\"bar-container\">\n                        <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"69%\"><\/div>\n                        <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"69%\">69%<\/div>\n                    <\/div>\n                    <span class=\"bar-legend\">Porcentaje de pacientes con patr\u00f3n de sue\u00f1o normalizado tras el fracaso de la medicaci\u00f3n<\/span>\n                     <div class=\"bar-legend-container\">\n                        <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora significativa<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n            <!-- End Gold Bar Section -->\n            <!-- Sec\u00e7\u00e3o Importante -->\n            <div class=\"important-info\">\n                <h4>Importante<\/h4>\n                <p>Es importante tener en cuenta que el tratamiento del Insomnio conlleva un factor determinante: el riesgo de adicci\u00f3n. La neuroterapia resuelve este problema. El uso intensivo y prolongado de f\u00e1rmacos para dormir tiene graves consecuencias que deben evitarse. Esta secci\u00f3n contiene informaci\u00f3n relevante sobre el Insomnio y los tratamientos presentados. Es fundamental tratar su caso concreto con un profesional sanitario.<\/p>\n            <\/div>\n            <!-- Fim da Sec\u00e7\u00e3o Importante -->\n             <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La EMT act\u00faa sobre las regiones cerebrales responsables del control del sue\u00f1o y el ritmo circadiano. Este tratamiento no farmacol\u00f3gico normaliza los patrones alterados de actividad cerebral en pacientes con insomnio, mejorando tanto la calidad del sue\u00f1o como el tiempo total dormido, sin los efectos secundarios ni los riesgos de dependencia asociados a los f\u00e1rmacos hipn\u00f3ticos.<\/p><\/div><div class=\"info-box\"><div class=\"info-item\"><h4><i>\u2713<\/i> Mejora de la calidad del sue\u00f1o<\/h4><p>Los pacientes afirman no s\u00f3lo dormir m\u00e1s, sino tambi\u00e9n tener un sue\u00f1o m\u00e1s reparador y reparador.<\/p><\/div><div class=\"info-item\"><h4><i>\u2713<\/i> Sin riesgo de dependencia<\/h4><p>A diferencia de muchos medicamentos contra el insomnio, la EMT no provoca dependencia ni tolerancia, ni siquiera con un uso prolongado.<\/p><\/div><\/div>\n            <!-- NOVO BLOCO IMAGEM + TEXTO + BOT\u00c3O \"VER ARTIGO\" -->\n            <div class=\"article-callout\">\n                <div class=\"article-callout-image-wrapper\">\n                    <!-- Imagem 3:2: Coloque a sua tag <img> aqui. O novo CSS vai faz\u00ea-la caber. -->\n                    <img decoding=\"async\" src=\"https:\/\/neuropsiquiatria.pt\/wp-content\/uploads\/2025\/07\/Insonia-ilustracao.webp\" alt=\"Imagem Ins\u00f3nia\">\n                <\/div>\n                <div class=\"article-callout-content\">\n                    <h4 class=\"article-callout-title\">Consulte el art\u00edculo \"La gu\u00eda completa: problemas de insomnio\/sue\u00f1o\"<\/h4>\n                    <p class=\"article-callout-description\">Todo lo que necesita saber para entender el Insomnio y el Sue\u00f1o.<\/p>\n                    <a href=\"https:\/\/neuropsiquiatria.pt\/es\/insonia-problemas-do-sono-o-guia-completo-2025\/\" class=\"secondary-action-btn article-callout-btn\">Ver art\u00edculo<\/a>\n                <\/div>\n            <\/div>\n        <\/div>\n        \n        <!-- ============================================== -->\n        <!-- NEW CONTENT BLOCKS (Placeholder Data) -->\n        <!-- ============================================== -->\n\n        <!-- TDAH\/PHDA (COM ALTERA\u00c7\u00c3O) -->\n        <div class=\"pain-content\" id=\"tdah\">\n    <div class=\"pain-header\">\n        <h3>TDAH<\/h3>\n        <p>El Trastorno por D\u00e9ficit de Atenci\u00f3n e Hiperactividad (TDAH) afecta a la atenci\u00f3n, el control de los impulsos y la actividad. Compara la eficacia de los tratamientos del TDAH.<\/p>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Mejora de los s\u00edntomas de falta de atenci\u00f3n e hiperactividad<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"35%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"75%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"35%\">35%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"75%\">75%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejora significativa de los s\u00edntomas (evaluados mediante una escala cl\u00ednica)<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa\/Normalizaci\u00f3n<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"14%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"75%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"14%\">14%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"75%\">75%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejor\u00eda significativa de los s\u00edntomas tras el protocolo de neuromodulaci\u00f3n (diana prefrontal, a menudo DLPFC derecha).<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa\/Normalizaci\u00f3n<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"60%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"60%\">60%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios (ansiedad, apat\u00eda, insomnio, disminuci\u00f3n del apetito...)<\/span>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"2%\">2%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n        <\/div>\n    <\/div>\n    \n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Mejora convencional tras un fallo<\/div>\n         <div class=\"treatment-bar\">\n            <span class=\"bar-label\">TMS (Postfallo convencional\/No respuesta)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"35%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"35%\">35%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes con mejor\u00eda significativa de los s\u00edntomas tras el fracaso de \u22651 medicaci\u00f3n<\/span>\n             <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"important-info\">\n        <h4>Importante<\/h4>\n        <p>El tratamiento con EMT suele utilizarse para mejorar la capacidad de concentraci\u00f3n y reducir la impulsividad en el TDAH, especialmente en adultos. Los porcentajes de remisi\u00f3n con medicaci\u00f3n reflejan su uso continuado. La neuroterapia ofrece una alternativa no sist\u00e9mica con menos efectos secundarios. Es crucial tratar su caso concreto con un profesional sanitario. <\/p>\n    <\/div>\n\n    <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La estimulaci\u00f3n magn\u00e9tica transcraneal (EMT) se centra en modular la actividad del c\u00f3rtex prefrontal (a menudo el DLPFC derecho), una zona clave para la funci\u00f3n ejecutiva y el control de la atenci\u00f3n. Este tratamiento puede restablecer el equilibrio de la actividad neuronal, mejorando la capacidad de concentraci\u00f3n y reduciendo la hiperactividad y la impulsividad sin necesidad de medicaci\u00f3n diaria.<\/p><\/div>\n    <div class=\"info-box\">\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Reducir la dependencia<\/h4><p>Permite reducir o eliminar la medicaci\u00f3n, evitando la dependencia y los efectos secundarios sist\u00e9micos.<\/p><\/div>\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Beneficio cognitivo<\/h4><p>Promueve mejoras en la funci\u00f3n ejecutiva, la memoria de trabajo y la velocidad de procesamiento, esenciales para el \u00e9xito acad\u00e9mico y profesional.<\/p><\/div>\n    <\/div>\n    <!-- NOVO BLOCO IMAGEM + TEXTO + BOT\u00c3O \"VER ARTIGO\" -->\n    <div class=\"article-callout\">\n        <div class=\"article-callout-image-wrapper\">\n            <!-- Imagem 3:2: Coloque a sua tag <img> aqui. O novo CSS vai faz\u00ea-la caber. -->\n            <img decoding=\"async\" src=\"https:\/\/neuropsiquiatria.pt\/wp-content\/uploads\/2025\/07\/ChatGPT-Image-18_07_2025-19_38_36.png\" alt=\"Imagem TDAH\">\n        <\/div>\n        <div class=\"article-callout-content\">\n          <h4 class=\"article-callout-title\">Ver el art\u00edculo \"La gu\u00eda completa: TDAH\/PHDA\"<\/h4>\n                    <p class=\"article-callout-description\">Todo lo que necesita saber para comprender el Trastorno por D\u00e9ficit de Atenci\u00f3n e Hiperactividad.<\/p>\n            <a href=\"https:\/\/neuropsiquiatria.pt\/es\/tdah-phda-o-guia-completo-2025\/\" class=\"secondary-action-btn article-callout-btn\">Ver art\u00edculo<\/a>\n        <\/div>\n    <\/div>\n<\/div>\n\n<!-- Tabagismo -->\n<div class=\"pain-content\" id=\"tabagismo\">\n    <div class=\"pain-header\">\n        <h3>Fumar<\/h3>\n        <p>El tabaquismo es una adicci\u00f3n compleja con altas tasas de reca\u00edda. Comparar la eficacia del enfoque convencional frente a la neuromodulaci\u00f3n en el proceso de abandono del tabaco.<\/p>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Tasa de abandono (abstinencia continua)<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Tratamiento convencional (farmacol\u00f3gico + terapia)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"20%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"35%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"20%\">20%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"35%\">35%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de abstinencia a los 6 meses de tratamiento<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Abstinencia sostenida (\u22656 meses)<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Abstinencia inicial (1-3 meses)<\/div>\n            <\/div>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"30%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"55%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"30%\">30%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"55%\">55%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de abstinencia verificadas a los 6 meses tras un ciclo completo de EMT (protocolos que implican redes prefrontales y, en EMT profunda, tambi\u00e9n la \u00ednsula).<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Abstinencia sostenida (\u22656 meses)<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Abstinencia inicial (1-3 meses)<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Tratamiento convencional (farmacol\u00f3gico)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"45%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"45%\">45%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que informan de efectos secundarios significativos (por ejemplo, cambios de humor, insomnio).<\/span>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"4%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"1%\">1%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n        <\/div>\n    <\/div>\n    \n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Reducir los antojos<\/div>\n         <div class=\"treatment-bar\">\n            <span class=\"bar-label\">TMS (Reducci\u00f3n del ansia)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"50%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"50%\">50%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes con una reducci\u00f3n significativa (\u226550%) del deseo de fumar tras un ciclo de EMT.<\/span>\n             <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Reducci\u00f3n de los antojos<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"important-info\">\n        <h4>Importante<\/h4>\n        <p>El \u00e9xito del tabaquismo est\u00e1 estrechamente ligado a la intensidad del ansia. La EMT act\u00faa directamente sobre las redes cerebrales implicadas en la recompensa y la adicci\u00f3n. El tratamiento es m\u00e1s eficaz cuando se combina con asesoramiento psicol\u00f3gico. Es fundamental tratar su caso concreto con un profesional sanitario.<\/p>\n    <\/div>\n\n    <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La EMT se dirige a la corteza prefrontal dorsolateral (CPDL) y a los circuitos de recompensa; en la EMT profunda, los protocolos espec\u00edficos incluyen tambi\u00e9n la \u00ednsula. Al modular estas redes, la EMT reduce el deseo de fumar, facilita la abstinencia y reduce la tasa de reca\u00eddas a largo plazo, ofreciendo una intervenci\u00f3n no sist\u00e9mica.<\/p><\/div>\n    <div class=\"info-box\">\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Atacar el ansia<\/h4><p>Act\u00faa directamente sobre las v\u00edas de adicci\u00f3n del cerebro, reduciendo el deseo f\u00edsico de fumar.<\/p><\/div>\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Sin reacciones adversas<\/h4><p>El tratamiento evita las reacciones adversas sist\u00e9micas habituales de algunos f\u00e1rmacos para dejar de fumar.<\/p><\/div>\n    <\/div>\n<\/div>\n\n<!-- Stress P\u00f3s-Traum\u00e1tico (PTSD\/TSPT) -->\n<div class=\"pain-content\" id=\"stress-post-traumatico\">\n    <div class=\"pain-header\">\n        <h3>Trastorno de estr\u00e9s postraum\u00e1tico (TEPT\/TSPT)<\/h3>\n        <p>El trastorno de estr\u00e9s postraum\u00e1tico (TEPT\/TSPT) se caracteriza por recuerdos intrusivos e hipervigilancia. Compare la eficacia de los tratamientos.<\/p>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Mejor\u00eda sintom\u00e1tica (reducci\u00f3n de &gt;50%)<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n + psicoterapia)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"4%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"30%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"4%\">4%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"30%\">30%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejor\u00eda significativa de los s\u00edntomas (DSM-5) tras un tratamiento prolongado.<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"12%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"55%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"12%\">12%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"55%\">55%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejor\u00eda significativa de los s\u00edntomas tras protocolo de neuromodulaci\u00f3n (EMTr; series \u226510-20 sesiones tienden a mejor respuesta)<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"70%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"70%\">70%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios (por ejemplo, somnolencia, aumento de peso)<\/span>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"3%\">3%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n        <\/div>\n    <\/div>\n    \n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Mejora convencional tras un fallo<\/div>\n         <div class=\"treatment-bar\">\n            <span class=\"bar-label\">TMS (Postfallo convencional)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"40%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"40%\">40%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes con mejor\u00eda significativa tras el fracaso de \u22651 tratamiento convencional<\/span>\n             <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"important-info\">\n        <h4>Importante<\/h4>\n        <p>El TEPT se caracteriza por cambios en la excitabilidad del cerebro. La EMT se centra en reequilibrar esta excitabilidad, especialmente en las \u00e1reas de la memoria emocional y la regulaci\u00f3n del estado de \u00e1nimo. El tratamiento ideal debe combinar la neuromodulaci\u00f3n y la terapia psicol\u00f3gica centrada en el trauma. Es crucial tratar su caso concreto con un profesional sanitario. <\/p>\n    <\/div>\n\n    <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La estimulaci\u00f3n magn\u00e9tica transcraneal (EMT) utiliza impulsos magn\u00e9ticos para modular la actividad del c\u00f3rtex prefrontal (a menudo el derecho) e, indirectamente, los circuitos l\u00edmbicos. El objetivo es reducir la hiperexcitabilidad asociada a la ansiedad, la hipervigilancia y los recuerdos traum\u00e1ticos, favoreciendo una mayor regulaci\u00f3n emocional.<\/p><\/div>\n    <div class=\"info-box\">\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Alivio de la ansiedad<\/h4><p>Reducci\u00f3n de los recuerdos intrusivos y de la respuesta de sobresalto, lo que permite una mayor comodidad en la vida cotidiana.<\/p><\/div>\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Mejora del sue\u00f1o<\/h4><p>Ayuda a restablecer patrones de sue\u00f1o saludables, a menudo interrumpidos por pesadillas e hipervigilancia nocturna.<\/p><\/div>\n    <\/div>\n<\/div>\n\n<!-- P\u00f3s-AVC -->\n<div class=\"pain-content\" id=\"pos-avc\">\n    <div class=\"pain-header\">\n        <h3>Post-ictus (recuperaci\u00f3n neurol\u00f3gica)<\/h3>\n        <p>La recuperaci\u00f3n tras un ictus puede ser un reto de larga duraci\u00f3n. Compara la eficacia de la rehabilitaci\u00f3n convencional con los m\u00e9todos de neuromodulaci\u00f3n.<\/p>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Mejora de la funci\u00f3n motora (NIHSS y escalas cl\u00ednicas)<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Rehabilitaci\u00f3n convencional (fisioterapia\/terapia ocupacional)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"15%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"60%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"15%\">15%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"60%\">60%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de recuperaci\u00f3n motora completa y mejora significativa tras la rehabilitaci\u00f3n est\u00e1ndar (&gt;6 meses)<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Recuperaci\u00f3n completa de la funci\u00f3n motora<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa de la funci\u00f3n motora<\/div>\n            <\/div>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n transcraneal por corriente continua (tDCS) + Rehabilitaci\u00f3n<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"18%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"85%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"18%\">18%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"85%\">85%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de recuperaci\u00f3n y mejora significativa de la funci\u00f3n motora (beneficio adicional cuando se combina con rehabilitaci\u00f3n).<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Recuperaci\u00f3n completa de la funci\u00f3n motora<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa de la funci\u00f3n motora<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Mejorar la funci\u00f3n del lenguaje (afasia)<\/div>\n         <div class=\"treatment-bar\">\n            <span class=\"bar-label\">tDCS + logopedia (despu\u00e9s de un ictus)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"58%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"58%\">58%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes con mejor\u00eda significativa (\u226550%) en la comprensi\u00f3n\/expresi\u00f3n verbal tras la terapia combinada.<\/span>\n             <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora ling\u00fc\u00edstica<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n    \n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Tasa de efectos secundarios adicionales<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n transcraneal por corriente continua (tDCS)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"4%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"1%\">1%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados adicionales a la rehabilitaci\u00f3n<\/span>\n        <\/div>\n    <\/div>\n    \n\n    <div class=\"important-info\">\n        <h4>Importante<\/h4>\n        <p>La tDCS acelera y potencia los beneficios de la rehabilitaci\u00f3n convencional modulando la plasticidad cerebral. Es m\u00e1s eficaz cuando se integra en el programa de rehabilitaci\u00f3n. El objetivo es reactivar la zona da\u00f1ada o hacer que otras zonas asuman la funci\u00f3n perdida. Es crucial tratar su caso concreto con un profesional sanitario.<\/p>\n    <\/div>\n\n    <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La estimulaci\u00f3n transcraneal por corriente continua (tDCS) aplica una corriente de baja intensidad para aumentar la excitabilidad (plasticidad) del hemisferio cerebral afectado por el ictus y\/o disminuir la excitabilidad del hemisferio no afectado (que la inhibe). Este proceso acelera la reorganizaci\u00f3n neuronal, mejorando la recuperaci\u00f3n motora y del lenguaje cuando se combina con terapia.<\/p><\/div>\n    <div class=\"info-box\">\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Mejora la rehabilitaci\u00f3n<\/h4><p>Funciona como un \"turbo\" para la neuroplasticidad, haciendo que las sesiones de rehabilitaci\u00f3n sean m\u00e1s productivas.<\/p><\/div>\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Ventana temporal<\/h4><p>Aunque es m\u00e1s eficaz en los primeros meses, la tDCS puede inducir mejoras incluso en fases cr\u00f3nicas (despu\u00e9s de 6 meses del ictus).<\/p><\/div>\n    <\/div>\n<\/div>\n\n<!-- TOC (COM ALTERA\u00c7\u00c3O) -->\n<div class=\"pain-content\" id=\"toc\">\n    <div class=\"pain-header\">\n        <h3>Trastorno obsesivo-compulsivo (TOC)<\/h3>\n        <p>El trastorno obsesivo-compulsivo (TOC) impone obsesiones y rituales que causan gran sufrimiento. Compara la eficacia de los tratamientos.<\/p>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Eficacia terap\u00e9utica (reducci\u00f3n sintom\u00e1tica &gt;35%)<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n + terapia)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"15%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"40%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"15%\">15%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"40%\">40%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejora significativa de los s\u00edntomas (evaluados mediante la escala Y-BOCS)<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-green\" style=\"width: 0%;\" data-width=\"22%\"><\/div>\n                <div class=\"bar bar-blue\" style=\"width: 0%;\" data-width=\"55%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-green\" style=\"width: 0%;\" data-width=\"22%\">22%<\/div>\n                <div class=\"bar-text-overlay bar-text-blue\" style=\"width: 0%; left: 0%;\" data-width=\"55%\">55%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Tasas medias de remisi\u00f3n y mejora significativa de los s\u00edntomas tras un protocolo de neuromodulaci\u00f3n (normalmente EMT profunda).<\/span>\n            <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-green\"><\/div> Remisi\u00f3n completa<\/div>\n                <div class=\"legend-item\"><div class=\"legend-color legend-blue\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Tasa de efectos secundarios<\/div>\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Tratamiento convencional (medicaci\u00f3n)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"70%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"70%\">70%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios significativos (por ejemplo, somnolencia, disfunci\u00f3n sexual)<\/span>\n        <\/div>\n\n        <div class=\"treatment-bar\">\n            <span class=\"bar-label\">Estimulaci\u00f3n magn\u00e9tica transcraneal (EMT)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-red\" style=\"width: 0%;\" data-width=\"5%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-red\" style=\"width: 0%;\" data-width=\"4%\">4%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes que declaran efectos secundarios moderados<\/span>\n        <\/div>\n    <\/div>\n    \n    <div class=\"treatment-comparison\">\n        <div class=\"comparison-title\">Mejora convencional tras un fallo<\/div>\n         <div class=\"treatment-bar\">\n            <span class=\"bar-label\">TMS (Postfallo convencional)<\/span>\n            <div class=\"bar-container\">\n                <div class=\"bar bar-gold\" style=\"width: 0%;\" data-width=\"45%\"><\/div>\n                <div class=\"bar-text-overlay bar-text-gold\" style=\"width: 0%;\" data-width=\"45%\">45%<\/div>\n            <\/div>\n            <span class=\"bar-legend\">Porcentaje de pacientes con mejor\u00eda significativa (\u226535%) tras el fracaso de \u22651 tratamiento convencional.<\/span>\n             <div class=\"bar-legend-container\">\n                <div class=\"legend-item\"><div class=\"legend-color legend-gold\"><\/div> Mejora significativa<\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n    <div class=\"important-info\">\n        <h4>Importante<\/h4>\n        <p>El TOC es un trastorno a menudo refractario. La neuroterapia ofrece una alternativa para los casos que no responden a la combinaci\u00f3n m\u00e1xima de ISRS (medicaci\u00f3n) y TCC (terapia cognitivo-conductual). La TCC act\u00faa sobre los circuitos frontoestriatales que sustentan las obsesiones y compulsiones. Es crucial que comentes tu caso concreto con un profesional sanitario.<\/p>\n    <\/div>\n\n    <div class=\"treatment-description\"><h4>\u00bfC\u00f3mo funciona nuestro tratamiento?<\/h4><p>La estimulaci\u00f3n magn\u00e9tica transcraneal (EMT) se dirige a las redes neuronales (c\u00f3rtex cingulado anterior y DLPFC) hiperactivas en el TOC y que alimentan el ciclo obsesi\u00f3n-compulsi\u00f3n. Al normalizar la actividad en estas zonas, la EMT reduce la intensidad y frecuencia de las obsesiones y la necesidad de realizar rituales compulsivos, lo que disminuye el sufrimiento del paciente.<\/p><\/div>\n    <div class=\"info-box\">\n        <div class=\"info-item\"><h4><i>\u2713<\/i> No invasivo y focalizado<\/h4><p>Permite un tratamiento centrado en las redes cerebrales disfuncionales, sin los efectos sist\u00e9micos de los f\u00e1rmacos.<\/p><\/div>\n        <div class=\"info-item\"><h4><i>\u2713<\/i> Casos refractarios<\/h4><p>Muy recomendable para pacientes que han fracasado en el tratamiento con medicaci\u00f3n y terapia psicol\u00f3gica.<\/p><\/div>\n    <\/div>\n    <!-- NOVO BLOCO IMAGEM + TEXTO + BOT\u00c3O \"VER ARTIGO\" -->\n    <div class=\"article-callout\">\n        <div class=\"article-callout-image-wrapper\">\n            <!-- Imagem 3:2: Coloque a sua tag <img> aqui. O novo CSS vai faz\u00ea-la caber. -->\n            <img decoding=\"async\" src=\"https:\/\/neuropsiquiatria.pt\/wp-content\/uploads\/2025\/06\/ChatGPT-Image-12_06_2025-15_55_07.png\" alt=\"Imagem TOC\">\n        <\/div>\n        <div class=\"article-callout-content\">\n            <h4 class=\"article-callout-title\">Ver el art\u00edculo \"La gu\u00eda completa: TOC\"<\/h4>\n                    <p class=\"article-callout-description\">Todo lo que necesita saber para comprender el Trastorno Obsesivo Compulsivo.<\/p>\n            <a href=\"https:\/\/neuropsiquiatria.pt\/es\/artigo-transtorno-obsessivo-compulsivo\/\" class=\"secondary-action-btn article-callout-btn\">Ver art\u00edculo<\/a>\n        <\/div>\n    <\/div>\n<\/div>\n\n<a href=\"https:\/\/neuropsiquiatria.pt\/es\/contactoselocalizacao\/\" class=\"action-btn\">Concertar una cita de evaluaci\u00f3n<\/a>\n    <\/div>\n\n    <script>\n        document.addEventListener('DOMContentLoaded', function() {\n            \/\/ NOTE: The .pain-tab elements are now hidden\/removed from HTML,\n            \/\/ but the logic here handles the dropdown exclusively for content switching.\n            const tabs = document.querySelectorAll('.pain-tab'); \/\/ Kept for reference, but should be empty or ignored\n            const contents = document.querySelectorAll('.pain-content');\n            \n            \/\/ Mobile dropdown elements (now universally used)\n            const dropdownTrigger = document.getElementById('dropdownTrigger');\n            const dropdownMenu = document.getElementById('dropdownMenu');\n            const dropdownItems = document.querySelectorAll('.dropdown-item');\n            const selectedOption = document.getElementById('selectedOption');\n\n            \/\/ Function to switch content\n            function switchContent(tabId, contentName) {\n                \/\/ 1. Hide all contents\n                contents.forEach(content => content.classList.remove('active'));\n                \n                \/\/ 2. Show the active content\n                const activeContent = document.getElementById(tabId);\n                if (activeContent) {\n                    activeContent.classList.add('active');\n                    animateBars(activeContent);\n                }\n\n                \/\/ 3. Update the displayed option text (if provided)\n                if (selectedOption && contentName) {\n                    selectedOption.textContent = contentName;\n                }\n            }\n\n            \/\/ Mobile\/Universal dropdown functionality\n            if (dropdownTrigger && dropdownMenu) {\n                dropdownTrigger.addEventListener('click', function(e) {\n                    e.stopPropagation(); \/\/ Prevents document click from immediately closing\n                    this.classList.toggle('active');\n                    dropdownMenu.classList.toggle('show');\n                });\n\n                dropdownItems.forEach(item => {\n                    item.addEventListener('click', function(e) {\n                        e.stopPropagation();\n                        const tabId = this.getAttribute('data-tab');\n                        const contentName = this.textContent;\n\n                        \/\/ Update active state in dropdown\n                        dropdownItems.forEach(i => i.classList.remove('active'));\n                        this.classList.add('active');\n                        \n                        \/\/ Switch content and update dropdown text\n                        switchContent(tabId, contentName);\n                        \n                        \/\/ Close dropdown\n                        dropdownTrigger.classList.remove('active');\n                        dropdownMenu.classList.remove('show');\n                        \n                        \/\/ Scroll to the content for better UX after selection\n                         const targetElement = document.getElementById(tabId);\n                         if (targetElement) {\n                             targetElement.scrollIntoView({ behavior: 'smooth', block: 'start' });\n                         }\n                    });\n                });\n\n                \/\/ Close dropdown when clicking outside\n                document.addEventListener('click', function(e) {\n                    if (!dropdownTrigger.contains(e.target) && !dropdownMenu.contains(e.target)) {\n                        dropdownTrigger.classList.remove('active');\n                        dropdownMenu.classList.remove('show');\n                    }\n                });\n            }\n\n\n            \/\/ *** Animate Bars function (Unchanged from original logic) ***\n            function animateBars(container) {\n                const treatmentBars = container.querySelectorAll('.treatment-bar');\n\n                treatmentBars.forEach(treatmentBar => {\n                    const greenBar = treatmentBar.querySelector('.bar-green');\n                    const blueBar = treatmentBar.querySelector('.bar-blue');\n                    const redBar = treatmentBar.querySelector('.bar-red');\n                    const goldBar = treatmentBar.querySelector('.bar-gold'); \/\/ Gold\n                    const textGreen = treatmentBar.querySelector('.bar-text-green');\n                    const textBlue = treatmentBar.querySelector('.bar-text-blue');\n                    const textRed = treatmentBar.querySelector('.bar-text-red');\n                    const textGold = treatmentBar.querySelector('.bar-text-gold'); \/\/ Gold\n\n                    \/\/ --- Reset elements within this treatmentBar ---\n                    if (greenBar) greenBar.style.width = '0%';\n                    if (blueBar) blueBar.style.width = '0%';\n                    if (redBar) redBar.style.width = '0%';\n                    if (goldBar) goldBar.style.width = '0%'; \n                    if (textGreen) textGreen.style.width = '0%';\n                    if (textBlue) {\n                        textBlue.style.width = '0%';\n                        textBlue.style.left = '0%';\n                    }\n                     if (textRed) textRed.style.width = '0%';\n                     if (textGold) textGold.style.width = '0%'; \n                    \/\/ --- End Reset ---\n\n\n                    \/\/ --- Animate Green ---\n                    setTimeout(() => {\n                        if (greenBar && textGreen) {\n                            const greenWidthStr = greenBar.getAttribute('data-width') || '0%';\n                            greenBar.style.width = greenWidthStr;\n                            textGreen.style.width = greenWidthStr;\n                        }\n                    }, 100);\n\n                    \/\/ --- Animate Blue ---\n                    setTimeout(() => {\n                        if (blueBar && textBlue) {\n                            const blueWidthStr = blueBar.getAttribute('data-width') || '0%';\n                            blueBar.style.width = blueWidthStr;\n\n                            let greenWidthStr = '0%';\n                            if (greenBar) {\n                                greenWidthStr = greenBar.getAttribute('data-width') || '0%';\n                            }\n\n                             \/\/ Correction: Ensure data-width uses '.' as decimal separator for JS parseFloat\n                            const greenWidthNum = parseFloat(greenWidthStr.replace(',', '.'));\n                            const blueWidthNum = parseFloat(blueWidthStr.replace(',', '.'));\n\n\n                            if (!isNaN(greenWidthNum) && !isNaN(blueWidthNum)) {\n                                const blueTextLeft = greenWidthNum + '%';\n                                const blueSegmentWidthNum = Math.max(0, blueWidthNum - greenWidthNum);\n                                const blueTextWidth = blueSegmentWidthNum + '%';\n\n                                textBlue.style.left = blueTextLeft;\n                                textBlue.style.width = blueTextWidth;\n                            } else {\n                                textBlue.style.left = '0%';\n                                textBlue.style.width = blueWidthStr; \/\/ Fallback if parsing fails\n                            }\n                        }\n                    }, 600);\n\n                    \/\/ --- Animate Red ---\n                    setTimeout(() => {\n                        if (redBar && textRed) {\n                            const redWidthStr = redBar.getAttribute('data-width') || '0%';\n                            redBar.style.width = redWidthStr;\n                            textRed.style.width = redWidthStr;\n                        }\n                    }, 1100);\n\n                    \/\/ --- Animate Gold ---\n                    setTimeout(() => {\n                        if (goldBar && textGold) {\n                            const goldWidthStr = goldBar.getAttribute('data-width') || '0%';\n                            goldBar.style.width = goldWidthStr;\n                            textGold.style.width = goldWidthStr;\n                        }\n                    }, 1100); \/\/ Same timing as red, adjust if needed\n\n\n                });\n            }\n\n\n            \/\/ Initial animation on the first active tab\n            const initialActiveTab = document.querySelector('.pain-content.active');\n            if (initialActiveTab) {\n                animateBars(initialActiveTab);\n            }\n\n            \/\/ Observer for animation on scroll\/visibility\n            const observer = new IntersectionObserver((entries) => {\n                entries.forEach(entry => {\n                    if (entry.isIntersecting && entry.target.classList.contains('active')) {\n                         animateBars(entry.target);\n                    }\n                });\n            }, { threshold: 0.2 });\n\n            contents.forEach(content => {\n                observer.observe(content);\n            });\n        });\n    <\/script>\n<\/body>\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-80c5f31 e-flex e-con-boxed e-con e-parent\" data-id=\"80c5f31\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-634001e elementor-widget elementor-widget-heading\" data-id=\"634001e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Fuentes<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-aeb9217 elementor-widget elementor-widget-text-editor\" data-id=\"aeb9217\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div><ul><li>K. Cress, MD, 2015<\/li><\/ul><div><p><a href=\"https:\/\/www.researchgate.net\/publication\/282835803_Treatment_of_Unipolar_Non-Psychotic_Major_Depressive_Disorder_with_Transcranial_Magnetic_Stimulation_Examining_TMS_Effects_on_Pharmacotherapy_Changes_Acute_and_Long-Term_Outcomes_from_a_Retrospective_\">Tratamiento del trastorno depresivo mayor unipolar no psic\u00f3tico con estimulaci\u00f3n magn\u00e9tica transcraneal: examen de los efectos de la EMT sobre los cambios farmacoterap\u00e9uticos y los resultados agudos y a largo plazo a partir de una evaluaci\u00f3n retrospectiva durante la pr\u00e1ctica cl\u00ednica habitual.<\/a><\/p><\/div><ul><li>Dalhuisen I, van Oostrom I, Spijker J, Wijnen B, van Exel E, van Mierlo H, de Waardt D, Arns M, Tendolkar I, van Eijndhoven P. rTMS as a Next Step in Antidepressant Nonresponders: A Randomised Comparison With Current Antidepressant Treatment Approaches. Am J Psychiatry. 2024 Sep 1;181(9):806-814. doi: 10.1176\/appi.ajp.20230556. Epub 2024 Aug 7. PMID: 39108161.<\/li><\/ul><div><p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39108161\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/39108161\/<\/a><\/p><\/div><ul><li>Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014 Dec;75(12):1394-401. doi: 10.4088\/JCP.13m08977. PMID: 25271871.<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25271871\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/25271871\/<\/a><\/li><\/ul><div>\u00a0<\/div><ul><li>Nguyen KH, Gordon LG. Coste-efectividad de la estimulaci\u00f3n magn\u00e9tica transcraneal repetitiva frente a la terapia antidepresiva para la depresi\u00f3n resistente al tratamiento. Value Health. 2015 Jul;18(5):597-604. doi: 10.1016\/j.jval.2015.04.004. PMID: 26297087.<\/li><\/ul><div><p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26297087\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26297087\/<\/a><\/p><\/div><ul><li>Demitrack MA, Thase ME. Importancia cl\u00ednica de la estimulaci\u00f3n magn\u00e9tica transcraneal (EMT) en el tratamiento de la depresi\u00f3n farmacorresistente: s\u00edntesis de datos recientes. Psychopharmacol Bull. 2009;42(2):5-38. PMID: 19629020.<\/li><\/ul><div><p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19629020\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/19629020\/<\/a><\/p><\/div><ul><li>Avery DH, Holtzheimer PE 3rd, Fawaz W, Russo J, Neumaier J, Dunner DL, Haynor DR, Claypoole KH, Wajdik C, Roy-Byrne P. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry. 2006 Jan 15;59(2):187-94. doi: 10.1016\/j.biopsych.2005.07.003. Epub 2005 Sep 1. PMID: 16139808.<\/li><\/ul><div><p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16139808\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16139808\/<\/a><\/p><\/div><ul><li>CHUC - Unidad de Neuromodulaci\u00f3n de la ULS de Coimbra<\/li><\/ul><div><p>Pr\u00e1ctica cl\u00ednica: \u2154 de los pacientes muestran una mejor\u00eda significativa; sin efectos secundarios significativos; remisi\u00f3n total significativa (se desconocen los datos exactos).<\/p><\/div><ul><li>Marilyn J. Vach\u00e8,Estimulaci\u00f3n magn\u00e9tica para el tratamiento del trastorno depresivo mayor en una poblaci\u00f3n severamente resistente al tratamiento- Una evaluaci\u00f3n retrospectiva en la pr\u00e1ctica privada,Estimulaci\u00f3n cerebral,Volume 8, Issue 5,2015,Page e6,ISSN 1935-861X,https:\/\/doi.org\/10.1016\/j.brs.2015.07.021.<\/li><\/ul><div><p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1935861X15010463\">https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1935861X15010463<\/a><\/p><\/div><ul><li><a href=\"https:\/\/medicine.yale.edu\/profile\/sherab-tsheringla\/\">Sherab Tsheringla, Doctor en Medicina<\/a>, <a href=\"https:\/\/medicine.yale.edu\/profile\/sherab-tsheringla\/\">Sherab Tsheringla, MD, MBBS<\/a><\/li><\/ul><div><p><a href=\"https:\/\/www.yalemedicine.org\/news\/transcranial-magnetic-stimulation-tms-what-you-need-to-know\">https:\/\/www.yalemedicine.org\/news\/transcranial-magnetic-stimulation-tms-what-you-need-to-know<\/a><\/p><\/div><ul><li>Mountain Vista, an\u00e1lisis cl\u00ednico retrospectivo<\/li><\/ul><div><p><a href=\"https:\/\/www.mountainvistapsychology.com\/neurofeedback-in-the-treatment-of-anxiety\/\">https:\/\/www.mountainvistapsychology.com\/neurofeedback-in-the-treatment-of-anxiety\/<\/a><\/p><\/div><ul><li>Revista Portuguesa de Psiquiatr\u00eda y Salud Mental<\/li><\/ul><div><p><a href=\"https:\/\/www.revistapsiquiatria.pt\/index.php\/sppsm\/article\/download\/477\/147\/3093\">https:\/\/www.revistapsiquiatria.pt\/index.php\/sppsm\/article\/download\/477\/147\/3093<\/a><\/p><\/div><ul><li>OMS<\/li><\/ul><div><p><a href=\"https:\/\/vlibrary.emro.who.int\/?goto=Q04jBjQNRBtEPjNfCxJARQYeNjhVTj4UTkUfUBlSC0YwehIWPCkgAWoqXyJoXDUoQhEhFhQ9QhYaByY0Jid3b0fY1-YGTQNVV6zDoyMCUlgaBbrL62Y2AsPr-HKU_PIadGdLmdnUY1-n66NMy6bNeAhjUlZKEXklazonNg\">https:\/\/vlibrary.emro.who.int\/?goto=Q04jBjQNRBtEPjNfCxJARQYeNjhVTj4UTkUfUBlSC0YwehIWPCkgAWoqXyJoXDUoQhEhFhQ9QhYaByY0Jid3b0fY1-YGTQNVV6zDoyMCUlgaBbrL62Y2AsPr-HKU_PIadGdLmdnUY1-n66NMy6bNeAhjUlZKEXklazonNg<\/a><\/p><\/div><ul><li>NIH, EE.UU.<\/li><\/ul><div><p><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5612370\/\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5612370\/<\/a><\/p><\/div><ul><li>Effect of Insomnia on Repetitive Transcranial Magnetic Stimulation Treatment Outcomes for Depression, Jamie Kweon, Andrew Fukuda, Polly Gobin, Lamaan Haq, Joshua C. Brown, Linda L. CarpentermedRxiv 2023.12.06.23299444; doi: https:\/\/doi.org\/10.1101\/2023.12.06.23299444<\/li><\/ul><div><p><a href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2023.12.06.23299444v1.full\">https:\/\/www.medrxiv.org\/content\/10.1101\/2023.12.06.23299444v1.full<\/a><\/p><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Neuroterapia VS Terapias Convenconais &#8211; Comparativo COMPARATIVO Neuroterapia VS Terapias Convencionais Depress\u00e3o MENU \u25bc Depress\u00e3o Dor Neurop\u00e1tica Enxaqueca Fibromialgia Ins\u00f3nia TDAH\/PHDA Tabagismo Stress P\u00f3s-Traum\u00e1tico P\u00f3s-AVC TOC Depress\u00e3o A depress\u00e3o afeta significativamente a qualidade de vida, causando sofrimento mental e f\u00edsico. Compare a efic\u00e1cia dos tratamentos convencionais com as nossas abordagens neurol\u00f3gicas avan\u00e7adas. Efic\u00e1cia Geral dos [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1066","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"_links":{"self":[{"href":"https:\/\/neuropsiquiatria.pt\/es\/wp-json\/wp\/v2\/pages\/1066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuropsiquiatria.pt\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/neuropsiquiatria.pt\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/neuropsiquiatria.pt\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neuropsiquiatria.pt\/es\/wp-json\/wp\/v2\/comments?post=1066"}],"version-history":[{"count":290,"href":"https:\/\/neuropsiquiatria.pt\/es\/wp-json\/wp\/v2\/pages\/1066\/revisions"}],"predecessor-version":[{"id":4520,"href":"https:\/\/neuropsiquiatria.pt\/es\/wp-json\/wp\/v2\/pages\/1066\/revisions\/4520"}],"wp:attachment":[{"href":"https:\/\/neuropsiquiatria.pt\/es\/wp-json\/wp\/v2\/media?parent=1066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}